Hilo Raises $19 Million Series B Extension to Expand AI-Powered Blood Pressure Monitoring

Hilo Secures $19 Million to Expand Continuous Blood Pressure Monitoring

Swiss healthtech company Hilo, developed by Aktiia, has raised a $19 million Series B extension, bringing its total funding to more than $119 million. The extension was backed by Dell Family Office and will support the company's expansion into the United States.

Founded in 2018 by Mattia Bertschi and Josep Solà, Hilo develops wearable technology that continuously monitors blood pressure using optical sensing technology combined with AI-powered analytics.

Advancing AI-Powered Cardiovascular Health

Hilo's platform combines a wrist-worn optical sensor, an FDA-cleared blood pressure cuff, and a mobile application to provide approximately 30 to 35 blood pressure readings per day, enabling users and healthcare professionals to monitor long-term cardiovascular trends.

The company says its technology has been validated through eight clinical studies and is already used by more than 200,000 people worldwide.

Supporting U.S. Expansion

The new funding will be used to accelerate Hilo's expansion across the U.S., invest in product development, and grow its team.

The company aims to improve hypertension management by providing continuous blood pressure insights that support earlier intervention and more informed treatment decisions.